계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
ViaCell
company
About
ViaCell is a biotechnology company focused on the area of women’s health.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $48M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 1993
- Number Of Employee
- 11 - 50
- Operating Status
- Active
ViaCell is a biotechnology company focused on the area of women’s health. The company develops ViaCord, which enables families preserve their baby’s umbilical cord blood at the time of birth for possible future medical use; and ViaCyte, to broaden reproductive choices for women through the cryopreservation of human unfertilized eggs.ViaCell is based in Boston, Massachusetts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$48M
ViaCell has raised a total of
$48M
in funding over 2 rounds. Their latest funding was raised on
Nov 14, 2000 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 14, 2000 | Series Unknown | $48M | 3 |
Nomura International
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
ViaCell is funded by 3 investors.
Nomura International
and Sofinov Societe Financiere D'Innovation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Nomura International
|
Yes | Series Unknown |
|
|
— | Series Unknown |
|
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
